Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic clinical trials, observational studies, and health surveys. In the context of RWE, patient recruitment plays a significant role, as the data collected from these individuals helps in understanding the effectiveness, safety, and usage of medical products in the real world.
Traditional Patient Recruitment: In traditional methods, patient recruitment generally happens through methods like physician referrals, media advertising, patient registries, and patient advocacy groups. This method can be time-consuming, costly, and sometimes inefficient, as it often relies on manual efforts. It can also be challenging to find patients who fit specific inclusion and exclusion criteria for a particular study.
AI-Enabled Recruitment: Artificial intelligence (AI) has started transforming patient recruitment in many ways. AI can analyze vast amounts of real-world data from electronic health records (EHRs), medical claims, health surveys, and other digital health platforms to identify eligible patients rapidly. This approach reduces the recruitment timeline and the costs associated with patient enrollment.
AI algorithms can predict the likelihood of patients participating in the study, improving the precision of recruitment. They can also monitor and analyze patient behavior, enabling the refinement of recruitment strategies in real-time. AI can further enhance the diversity of recruited patients by considering a wide range of demographic and geographic factors, leading to a more inclusive and representative study.
AI-enabled recruitment can also help in mitigating potential biases in patient selection by utilizing a data-driven approach. By analyzing historical clinical trial data, AI models can identify patterns and biases in previous studies and correct them in future ones. Furthermore, AI can help in patient retention by predicting the potential drop-out risks and enabling timely intervention.
In conclusion, while traditional methods are essential and remain relevant in certain contexts, AI-enabled recruitment offers the possibility of increased speed, reduced costs, and improved diversity and representativeness of patients in studies generating real-world evidence.
Share this story...
Real World Evidence (RWE) 101 – Data Tokenization
RWE 101 - 4 Potential Uses for Improving Drug Development Real world evidence (RWE) refers to data collected outside the context of traditional clinical trials, such as [...]
Real World Evidence (RWE) 101 – Primary Data versus Secondary Data
RWE 101 - Primary Data versus Secondary Data Primary data and secondary data are two types of data used in research. The main difference between the two [...]
RWE 101 – Secondary Use of Existing Data
RWE 101 - Secondary Use of Existing Data Secondary use of existing data refers to the practice of analyzing data that was collected for a different purpose [...]
RWE 101 – Why is there so much excitement about the use of AI in the context of real world evidence?
RWE 101 - Why is there so much excitement about the use of AI in the context of real world evidence? The use of Artificial Intelligence (AI) [...]
RWE 101 – What is the Difference Between an IRB and a REC?
RWE 101 - What is the Difference Between an IRB and a REC? An Institutional Review Board (IRB) and a Research Ethics Committee (REC) are two different [...]
RWE 101 – Do I Need IRB Approval for My Observational Study?
RWE 101 - Do I Need IRB Approval for My Observational Study? In general, observational studies that involve human subjects require Institutional Review Board (IRB) approval to [...]







